EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Macrophages and HLA-Class II Alleles in Multiple Sclerosis: Insights in Therapeutic Dynamics

Petros Prapas, Maria Anagnostouli iD

International Journal of Molecular Sciences · 04.07.2024 · 25 (13) · 7354

DOI: 10.3390/ijms25137354 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.07.2024. Verfasst von Petros Prapas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Immunogenetics Laboratory, First Department of Neurology, Aeginition University Hospital, School of Medicine, National and Kapodistrian Univ…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Macrophages, Alleles. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antigen presentation is a crucial mechanism that drives the T cell-mediated immune response and the development of Multiple Sclerosis (MS). Genetic alterations within the highly variable Major Histocompatibility Complex Class II (MHC II) have been proven to result in significant changes in the molecular basis of antigen presentation and the clinical course of patients with both Adult-Onset MS (AOMS) and Pediatric-Onset MS (POMS). Among the numerous polymorphisms of the Human Leucocyte Antigens (HLA), within MHC II complex, HLA-DRB1*15:01 has been labeled, in Caucasian ethnic groups, as a high-risk allele for MS due to the ability of its structure to increase affinity to Myelin Basic Protein (MBP) epitopes. This characteristic, among others, in the context of the trimolecular complex or immunological synapsis, provides the foundation for autoimmunity triggered by environmental or endogenous factors. As with all professional antigen presenting cells, macrophages are characterized by the expression of MHC II and are often implicated in the formation of MS lesions. Increased presence of M1 macrophages in MS patients has been associated both with progression and onset of the disease, each involving separate but similar mechanisms. In this critical narrative review, we focus on macrophages, discussing how HLA genetic alterations can promote dysregulation of this population’s homeostasis in the periphery and the Central Nervous System (CNS). We also explore the potential interconnection in observed pathological macrophage mechanisms and the function of the diverse structure of HLA alleles in neurodegenerative CNS, seen in MS, by comparing available clinical with molecular data through the prism of HLA-immunogenetics. Finally, we discuss available and experimental pharmacological approaches for MS targeting the trimolecular complex that are based on cell phenotype modulation and HLA genotype involvement and try to reveal fertile ground for the potential development of novel drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisMacrophagesAllelesHumansHistocompatibility Antigens Class IIAntigen PresentationGenetic Predisposition to DiseaseAnimalsPolymorphism, Genetic

Stichwörter der Autor:innen

HLAHLA-immunogeneticsT cellsimmune responsemacrophagesmicrogliamultiple sclerosis

Substanzen

Histocompatibility Antigens Class II

Autor:innen und Institutionen

  • Research Immunogenetics Laboratory, First Department of Neurology, Aeginition University Hospital, School of Medicine, National and Kapodistrian University of Athens, Vas. Sofias 72-74, 11528 Athens, Greece.
  • Multiple Sclerosis and Demyelinating Diseases Unit, Center of Expertise for Rare Demyelinating and Autoimmune Diseases of CNS, First Department of Neurology, School of Medicine, National and Kapodistrian University of A…

ORCID-Profile: Maria Anagnostouli

Zitieren

APA

Prapas, P., & Anagnostouli, M. (2024). Macrophages and HLA-Class II Alleles in Multiple Sclerosis: Insights in Therapeutic Dynamics. International Journal of Molecular Sciences, 25(13), 7354. https://doi.org/10.3390/ijms25137354

Vancouver

Prapas P, Anagnostouli M. Macrophages and HLA-Class II Alleles in Multiple Sclerosis: Insights in Therapeutic Dynamics. International Journal of Molecular Sciences. 2024;25(13):7354. doi:10.3390/ijms25137354

BibTeX
@article{Prapas2024,
  author = {Prapas, Petros and Anagnostouli, Maria},
  title = {Macrophages and HLA-Class II Alleles in Multiple Sclerosis: Insights in Therapeutic Dynamics},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {13},
  pages = {7354},
  doi = {10.3390/ijms25137354}
}
Kostenlos starten →